Clinical Trial Details

Short Title
Official Title
Neuroblastoma Biology Studies

Participants in this study are newly diagnosed with neuroblastoma, ganglioneuroblastoma, or ganglioneuroma.  The purpose of this research study is: 1) to analyze the biologic markers needed to choose therapy for participants' diseases. These include Shimada classification, and MYCN testing. 2) to study other tumor genetics and save slides for future research studies. This may lead to better understanding of the disease. 3) to collect and store tissues samples in a national neuroblastoma tissue bank for future studies.

Start Date
August 12, 2001
End Date
August 12, 2016
Gender Preference
Age Group
0 - 18 years
Principal Investigator
Ayman El-Sheikh, MD
Contact Info

Julie de la Garza, 319-356-3749

ANBL00B1 ; cancer ; el-sheikh ; ganglioneuroblastoma ; ganglioneuroma ; IRB#200105101 ; neuroblastoma ; pediatric ;

We'd welcome your feedback!

Please help us improve your experience on our website by completing a brief survey

Yes, I'll give feedback No, Thanks